DEPOMED INC's ticker is and the CUSIP is 249908AA2. A total of 45 filers reported holding DEPOMED INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $4,339,000 | +102.7% | 4,396,000 | +51.8% | 0.34% | +187.4% |
| Q4 2019 | $2,141,000 | -26.7% | 2,896,000 | -26.1% | 0.12% | -36.7% |
| Q3 2019 | $2,921,000 | -18.0% | 3,917,000 | -20.3% | 0.19% | -8.3% |
| Q2 2019 | $3,564,000 | -14.8% | 4,917,000 | -9.2% | 0.20% | -18.3% |
| Q1 2019 | $4,182,000 | +45.9% | 5,417,000 | +27.9% | 0.25% | +30.7% |
| Q4 2018 | $2,867,000 | -42.8% | 4,236,000 | -31.0% | 0.19% | -17.9% |
| Q2 2018 | $5,009,000 | +32.0% | 6,136,000 | +32.4% | 0.23% | +23.8% |
| Q1 2018 | $3,796,000 | +1.1% | 4,636,000 | +4.5% | 0.19% | +2.2% |
| Q4 2017 | $3,755,000 | +140.9% | 4,436,000 | +111.2% | 0.18% | +143.4% |
| Q3 2017 | $1,559,000 | +18.0% | 2,100,000 | +40.0% | 0.08% | +18.8% |
| Q2 2017 | $1,321,000 | +412.0% | 1,500,000 | +445.5% | 0.06% | +326.7% |
| Q1 2017 | $258,000 | -96.0% | 275,000 | -95.1% | 0.02% | -95.8% |
| Q4 2016 | $6,500,000 | -59.3% | 5,660,000 | -49.3% | 0.36% | -54.1% |
| Q3 2016 | $15,976,000 | +99.5% | 11,160,000 | +67.6% | 0.77% | +44.5% |
| Q2 2016 | $8,008,000 | +38.8% | 6,660,000 | +8.2% | 0.54% | +50.7% |
| Q1 2016 | $5,771,000 | -26.7% | 6,153,000 | -10.9% | 0.36% | -24.0% |
| Q4 2015 | $7,871,000 | -52.4% | 6,903,000 | -50.3% | 0.47% | -52.0% |
| Q3 2015 | $16,529,000 | +74.1% | 13,879,000 | +87.4% | 0.97% | +119.6% |
| Q2 2015 | $9,496,000 | -43.0% | 7,408,000 | -41.2% | 0.44% | -47.7% |
| Q1 2015 | $16,669,000 | +858.5% | 12,600,000 | +687.5% | 0.85% | +884.9% |
| Q4 2014 | $1,739,000 | – | 1,600,000 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|